First Time Loading...
X

Xilio Therapeutics Inc
NASDAQ:XLO

Watchlist Manager
Xilio Therapeutics Inc
NASDAQ:XLO
Watchlist
Price: 1.18 USD 12.38% Market Closed
Updated: May 5, 2024

Income Statement

Earnings Waterfall
Xilio Therapeutics Inc

Revenue
0 USD
Operating Expenses
-79.1m USD
Operating Income
-79.1m USD
Other Expenses
2.7m USD
Net Income
-76.4m USD

Income Statement
Xilio Therapeutics Inc

Rotate your device to view
Income Statement
Currency: USD
Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023
Revenue
Revenue
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
Operating Income
Operating Expenses
(55)
(63)
(75)
(76)
(75)
(80)
(81)
(86)
(89)
(91)
(87)
(84)
(79)
Selling, General & Administrative
(11)
(13)
(16)
(19)
(24)
(25)
(28)
(30)
(30)
(31)
(30)
(29)
(27)
Research & Development
(44)
(50)
(59)
(58)
(51)
(54)
(53)
(56)
(59)
(60)
(57)
(55)
(52)
Operating Income
(55)
N/A
(63)
-16%
(75)
-18%
(76)
-2%
(75)
+1%
(80)
-6%
(81)
-2%
(86)
-5%
(89)
-4%
(91)
-3%
(87)
+5%
(84)
+3%
(79)
+6%
Pre-Tax Income
Interest Income Expense
(1)
0
0
0
(1)
(0)
(0)
(1)
(1)
(1)
(1)
(1)
(1)
Total Other Income
(0)
(0)
(1)
(1)
(0)
(0)
(0)
1
2
3
4
4
3
Pre-Tax Income
(55)
N/A
(64)
-15%
(75)
-18%
(77)
-2%
(76)
+1%
(80)
-6%
(82)
-2%
(85)
-4%
(88)
-3%
(90)
-1%
(84)
+6%
(81)
+4%
(76)
+6%
Net Income
Income from Continuing Operations
(55)
(64)
(75)
(77)
(76)
(80)
(82)
(85)
(88)
(90)
(84)
(81)
(76)
Net Income (Common)
(55)
N/A
(64)
-15%
(75)
-18%
(77)
-2%
(76)
+1%
(80)
-6%
(82)
-2%
(85)
-4%
(88)
-3%
(90)
-1%
(84)
+6%
(81)
+4%
(76)
+6%
EPS (Diluted)
-2.07
N/A
-2.4
-16%
-2.84
-18%
-2.89
-2%
-2.84
+2%
-2.94
-4%
-2.99
-2%
-3.11
-4%
-3.22
-4%
-3.27
-2%
-3.07
+6%
-2.96
+4%
-2.78
+6%

See Also

Discover More